Isolated liver perfusion (IHP) for unresectable liver metastasis: leakage monitoring, pharmacokinetics and hepatic toxicity

被引:0
|
作者
Casara, D. [1 ]
Mocellin, S. [2 ]
Arman, G. [2 ]
Nitti, D. [2 ]
Rossi, C. R. [2 ]
Pilati, P. [2 ]
机构
[1] IRCCS, Inst Oncol Veneto, Padua, Italy
[2] Univ Padua, Dept Surg & Oncol Sci, Padua, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S188 / S188
页数:1
相关论文
共 50 条
  • [1] Isolated liver perfusion for unresectable tumors: Correlation between drug pharmacokinetics and hepatic toxicity
    Pilati, P.
    Da Pian, R.
    Mocellin, S.
    Forlin, M.
    Corazzina, S.
    Nitti, D.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 33 - 33
  • [2] Correlation between melphalan pharmacokinetics and hepatic toxicity following hyperthermic isolated liver perfusion for unresectable metastatic disease
    Mocellin, Simone
    Pilati, Pierluigi
    Da Pian, Pierpaolo
    Forlin, Marco
    Corazzina, Susanna
    Rossi, Carlo Riccardo
    Innocente, Federico
    Ori, Carlo
    Casara, Dario
    Ujka, Francesca
    Nitti, Donato
    Lise, Mario
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 802 - 809
  • [3] Correlation Between Melphalan Pharmacokinetics and Hepatic Toxicity Following Hyperthermic Isolated Liver Perfusion for Unresectable Metastatic Disease
    Simone Mocellin
    Pierluigi Pilati
    Pierpaolo Da Pian
    Marco Forlin
    Susanna Corazzina
    Carlo Riccardo Rossi
    Federico Innocente
    Carlo Ori
    Dario Casara
    Francesca Ujka
    Donato Nitti
    Mario Lise
    [J]. Annals of Surgical Oncology, 2007, 14 : 802 - 809
  • [4] Isolated hepatic perfusion: Treating unresectable liver metastases
    Farma, Jeffrey M.
    Pingpank, James F.
    Alexander, H. Richard
    [J]. LIVER AND PANCREATIC DISEASES MANAGEMENT, 2006, 574 : 1 - 16
  • [5] Isolated hepatic perfusion is effective therapy for unresectable, isolated liver metastases
    D'Alessio, M. J.
    Anunobi, R.
    Gamblin, T. C.
    Holtzman, M.
    Pappas, S.
    Brown, C. K.
    Zeh, H. J.
    Bartlett, D. L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 105 - 105
  • [6] Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies
    Mark C. Burgmans
    Eleonora M. de Leede
    Christian H. Martini
    Ellen Kapiteijn
    Alexander L. Vahrmeijer
    Arian R. van Erkel
    [J]. CardioVascular and Interventional Radiology, 2016, 39 : 801 - 814
  • [7] Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies
    Burgmans, Mark C.
    de Leede, Eleonora M.
    Martini, Christian H.
    Kapiteijn, Ellen
    Vahrmeijer, Alexander L.
    van Erkel, Arian R.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (06) : 801 - 814
  • [8] Hyperthermic isolated hepatic perfusion for the treatment of unresectable cancers confined to the liver
    Carroll, NM
    Alexander, HR
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2002, 80 (01) : 64 - 65
  • [9] Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion (IHP) for unresectable liver metastases (LM) from colorectal cancer (CRC)
    Alexander, H.
    Pingpank, J. F.
    Libutti, S. K.
    Bartlett, D. L.
    Fraker, D. L.
    Royal, R. E.
    Steinberg, S. M.
    Beresnev, T. H.
    Helsabeck, C. B.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 5 - 6
  • [10] A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer
    Magge, D.
    Zureikat, A. H.
    Bartlett, D. L.
    Holtzman, M. P.
    Choudry, H. A.
    Beumer, J. H.
    Pingpank, J. F.
    Holleran, J. L.
    Strychor, S.
    Cunningham, D. E.
    Jones, H. L.
    Zeh, H. J., III
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2180 - 2187